Increased Serum Levels of Mesencephalic Astrocyte-Derived Neurotrophic Factor in Subjects With Parkinson’s Disease

Levels of glial cell line‐derived neurotrophic factor are decreased, but fibroblast growth factor 2 and cerebral dopamine neurotrophic factor are increased in the hippocampus in parkinson's disease

(2019) Sophie Virachit et al.   BRAIN PATHOLOGY

CDNF Protein Therapy in Parkinson’s Disease

(2019) Henri J. Huttunen et al.   CELL TRANSPLANTATION

Long-term protective effects of AAV9-mesencephalic astrocyte-derived neurotrophic factor gene transfer in parkinsonian rats

(2017) Fei Hao et al.   EXPERIMENTAL NEUROLOGY

Unconventional neurotrophic factors CDNF and MANF: Structure, physiological functions and therapeutic potential

(2017) Maria Lindahl et al.   NEUROBIOLOGY OF DISEASE

Parkinson disease

(2017) Werner Poewe et al.   Nature Reviews Disease Primers

Review: Sporadic Parkinson's disease: development and distribution ofα-synuclein pathology

(2016) K. Del Tredici et al.   NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY

Comparative Analysis of the Effects of Neurotrophic Factors CDNF and GDNF in a Nonhuman Primate Model of Parkinson’s Disease

(2016) Enrique Garea-Rodríguez et al.   PLoS One

Increased circulating concentrations of mesencephalic astrocyte-derived neurotrophic factor in children with type 1 diabetes

(2016) Emilia Galli et al.   Scientific Reports

Health-related quality of life in Parkinson’s disease: a cross-sectional study focusing on non-motor symptoms

(2015) Liis Kadastik-Eerme et al.   Health and Quality of Life Outcomes

Deficiency of IRE1 and PERK Signal Pathways in Systemic Lupus Erythematosus

(2014) Qiyao Cheng et al.   AMERICAN JOURNAL OF THE MEDICAL SCIENCES

Spatiotemporal Expression of MANF in the Developing Rat Brain

(2014) Haiping Wang et al.   PLoS One

AAV2-mediated striatum delivery of human CDNF prevents the deterioration of midbrain dopamine neurons in a 6-hydroxydopamine induced parkinsonian rat model

(2013) Xinmiao Ren et al.   EXPERIMENTAL NEUROLOGY

Gene therapy with AAV2-CDNF provides functional benefits in a rat model of Parkinson's disease

(2013) Susanne Bäck et al.   Brain and Behavior

MANF regulates dopaminergic neuron development in larval zebrafish

(2012) Y.-C. Chen et al.   DEVELOPMENTAL BIOLOGY

CDNF Protects the Nigrostriatal Dopamine System and Promotes Recovery after MPTP Treatment in Mice

(2011) Mikko Airavaara et al.   CELL TRANSPLANTATION

Clinical progression in Parkinson disease and the neurobiology of axons

(2010) Hsiao-Chun Cheng et al.   ANNALS OF NEUROLOGY

Mesencephalic Astrocyte-Derived Neurotrophic Factor Is Neurorestorative in Rat Model of Parkinson's Disease

(2009) M. H. Voutilainen et al.   JOURNAL OF NEUROSCIENCE

Evidence that DmMANF is an invertebrate neurotrophic factor supporting dopaminergic neurons

(2009) M. Palgi et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

The accuracy of diagnosis of major depression in patients with Parkinson's disease: a comparative study among the UPDRS, the geriatric depression scale and the Beck depression inventory

(2008) Vitor Tumas et al.   ARQUIVOS DE NEURO-PSIQUIATRIA

MANF is widely expressed in mammalian tissues and differently regulated after ischemic and epileptic insults in rodent brain

(2008) Päivi Lindholm et al.   MOLECULAR AND CELLULAR NEUROSCIENCE

Movement Disorder Society-sponsored revision of the Unified Parkinson's Disease Rating Scale (MDS-UPDRS): Scale presentation and clinimetric testing results

(2008) Christopher G. Goetz et al.   MOVEMENT DISORDERS